{"id":7219,"date":"2024-09-09T17:10:16","date_gmt":"2024-09-09T15:10:16","guid":{"rendered":"https:\/\/fonds-clinatec.fr\/when-infrared-light-stabilises-parkinsons-disease\/"},"modified":"2024-09-10T10:05:40","modified_gmt":"2024-09-10T08:05:40","slug":"when-infrared-light-stabilises-parkinsons-disease","status":"publish","type":"post","link":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/","title":{"rendered":"When infrared light stabilises Parkinson&#8217;s disease"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"7219\" class=\"elementor elementor-7219 elementor-7195\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a788ca0 e-flex e-con-boxed e-con e-parent\" data-id=\"a788ca0\" data-element_type=\"container\" data-settings=\"{&quot;container_type&quot;:&quot;flex&quot;,&quot;content_width&quot;:&quot;boxed&quot;}\" data-core-v316-plus=\"true\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9e49002 elementor-widget elementor-widget-image\" data-id=\"9e49002\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.19.0 - 07-02-2024 *\/\n.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=\".svg\"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}<\/style>\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"593\" height=\"592\" src=\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png\" class=\"attachment-large size-large wp-image-6897\" alt=\"d\u00e9monstrateur NIR, implant c\u00e9r\u00e9bral pour lutter contre la maladie de Parkinson\" srcset=\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png 593w, https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR-300x300.png 300w, https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR-150x150.png 150w\" sizes=\"(max-width: 593px) 100vw, 593px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bb9a45f textegris elementor-widget elementor-widget-text-editor\" data-id=\"bb9a45f\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.19.0 - 07-02-2024 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p><strong>The press is talking about us!<\/strong><br \/>A fine article published this weekend in Le Monde highlights the presentation given by Prof. Stephan Chabard\u00e8s, neurosurgeon, head of the neurosurgery department at Grenoble Alpes University Hospital and head of the Clinatec hospital sector, at the WSSFN 2024 (World Congress of Stereotactic and Functional Neurosurgery) in Chicago on the use of intracranial photobiomodulation to stabilise Parkinson&#8217;s disease and the initial results of the associated clinical trial. <\/p>\n<blockquote>\n<p>The Fonds Clinatec is particularly pleased and proud to have been able to contribute to this breakthrough from the outset, thanks to the support of its sponsors. Once again, Clinatec is opening up an unprecedented path towards a non-drug therapeutic solution that is likely to improve patients&#8217; quality of life. Dr Laurent H\u00e9rault, Director of the Fonds Clinatec.  <\/p>\n<\/blockquote>\n<p><strong><a style=\"font-family: var( --e-global-typography-text-font-family ), Sans-serif; font-size: var( --e-global-typography-text-font-size ); font-weight: var( --e-global-typography-text-font-weight ); letter-spacing: var( --e-global-typography-text-letter-spacing ); text-align: var(--text-align); background-color: #ffffff;\" href=\"https:\/\/www.lemonde.fr\/sciences\/article\/2024\/09\/08\/quand-la-lumiere-infrarouge-stabilise-la-maladie-de-parkinson_6307042_1650684.html\">Link to the article in Le Monde<\/a><\/strong><span style=\"color: var( --e-global-color-text ); font-family: var( --e-global-typography-text-font-family ), Sans-serif; font-size: var( --e-global-typography-text-font-size ); font-weight: var( --e-global-typography-text-font-weight ); letter-spacing: var( --e-global-typography-text-letter-spacing ); text-align: var(--text-align);\"><strong> <\/strong> <\/span><\/p>\n<\/p>\n<p><strong>Read the abstract of the oral communication by Professor Chabard\u00e8s<br \/>(in English)<\/strong><\/p>\n<p><strong>RESTORING DOPAMINERGIC FUNCTION AFTER CHRONIC INTRACRANIAL PHOTOBIOMODULATION IN DE NOVO PARKINSON\u2019S PATIENTS: A PROOF OF CONCEPT<\/strong><\/p>\n<p><span style=\"text-decoration: underline;\">Introduction<\/span><br \/>Recent studies in animal models of Parkinson&#8217;s disease (PD) have indicated that photobiomodulation (PBM) i.e., the use of red to near infrared light (\u03bb=600-1300 nm) on body tissues, reduces the degeneration of midbrain dopaminergic neurons with favorable safety profile. Most manifestations of PD are related to the loss of dopaminergic neurons located in the substantia nigra pars compacta (SNc). Mitochondrial dysfunction is one of the key mechanisms leading to neurodegeneration in PD.  <\/p>\n<p>PBM restore mitochondrial function, resulting in an increase in adenosine triphosphate (ATP) energy production in cells and therefore can enhance survival of dopaminergic neurons and improve motor behaviour.<\/p>\n<p>Here we report the first-in-man clinical and imaging data at 2 years f.up in 2 de novo PD patients fitted with a bespoke intracranial device delivering 670 nm light close to both SNc. We compared those data to 2 matched controls PD patients. The patients are part of a larger randomized, open-label case-control study (NCT04261569).  <\/p>\n<p><span style=\"text-decoration: underline;\">Methods<\/span><br \/>Four patients newly diagnosis with PD (less than 2 years), naive of any treatments were randomised to either PBM or control group. The probe of the PBM device was implanted into the floor of the 3rd ventricle, connected to a rechargeable battery. Clinical and PET imaging evaluation were compared to baseline and included among others MDS-UPDRS scale performed every 6 months and PET imaging every year using [11C]PE2I ligand.  <\/p>\n<p><span style=\"text-decoration: underline;\">Results<\/span><br \/>No abnormal feeling nor adverse events were noticed by the patients after chronic PBM. PBM Group: MDS-UPDRS scores part III improved at 24 months, from 38\/132 to 23\/132 and from 18\/132 to 17\/132 in patient#1 and #2 respectively, off drugs conditions. Control group: MDS-UPDRS scores part III deteriorated as expected from 20\/132 to 33\/132 and from 29\/132 to 38\/132 in patient#3 and #4 respectively, off drugs conditions.  <\/p>\n<p>With PBM, [11C]PE2I-PET at 12 (patient#1) and 18 months (patient#2) showed a remarkable increase of the [<sup>11<\/sup>C]PE2I BP<sub>ND<\/sub> in the caudate nucleus, the nucleus accumbens and the putamen. The [11C]PE2I BPND decreased as expected in all basal ganglia in controls patients. <\/p>\n<p><span style=\"text-decoration: underline;\">Conclusions<\/span><br \/>PBM is well tolerated and show promise for stabilzing motor symptoms and restoraring partially dopaminergic function<\/p>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Read the article in Le Monde on the work of Professor Chabard\u00e8s presented at the World Congress of Stereotactic and Functional Neurosurgery in Chicago. <\/p>\n","protected":false},"author":2,"featured_media":6897,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46,39,53],"tags":[],"class_list":["post-7219","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pbm-photobiomodulation-en","category-news","category-press"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>When infrared light stabilises Parkinson&#039;s disease - Fonds Clinatec<\/title>\n<meta name=\"description\" content=\"Read the article in Le Monde on the work of Professor Chabard\u00e8s presented at the World Congress of Stereotactic and Functional Neurosurgery in Chicago.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"When infrared light stabilises Parkinson&#039;s disease - Fonds Clinatec\" \/>\n<meta property=\"og:description\" content=\"Read the article in Le Monde on the work of Professor Chabard\u00e8s presented at the World Congress of Stereotactic and Functional Neurosurgery in Chicago.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Fonds Clinatec\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-09T15:10:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-10T08:05:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png\" \/>\n\t<meta property=\"og:image:width\" content=\"593\" \/>\n\t<meta property=\"og:image:height\" content=\"592\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nad\u00e8ge Canton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nad\u00e8ge Canton\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/\"},\"author\":{\"name\":\"Nad\u00e8ge Canton\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/person\/becc42595d617bcb9ded259df3f001d2\"},\"headline\":\"When infrared light stabilises Parkinson&#8217;s disease\",\"datePublished\":\"2024-09-09T15:10:16+00:00\",\"dateModified\":\"2024-09-10T08:05:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/\"},\"wordCount\":514,\"publisher\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png\",\"articleSection\":[\"(PBM) Photobiomodulation\",\"News\",\"Press\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/\",\"url\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/\",\"name\":\"When infrared light stabilises Parkinson's disease - Fonds Clinatec\",\"isPartOf\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png\",\"datePublished\":\"2024-09-09T15:10:16+00:00\",\"dateModified\":\"2024-09-10T08:05:40+00:00\",\"description\":\"Read the article in Le Monde on the work of Professor Chabard\u00e8s presented at the World Congress of Stereotactic and Functional Neurosurgery in Chicago.\",\"breadcrumb\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#primaryimage\",\"url\":\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png\",\"contentUrl\":\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png\",\"width\":593,\"height\":592,\"caption\":\"d\u00e9monstrateur NIR, implant c\u00e9r\u00e9bral pour lutter contre la maladie de Parkinson\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/fonds-clinatec.fr\/en\/homepage\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"When infrared light stabilises Parkinson&#8217;s disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#website\",\"url\":\"https:\/\/fonds-clinatec.fr\/en\/\",\"name\":\"Fonds Clinatec\",\"description\":\"Make the impossible possible\",\"publisher\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fonds-clinatec.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#organization\",\"name\":\"Fonds Clinatec\",\"url\":\"https:\/\/fonds-clinatec.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2023\/07\/logo-clinatec.png\",\"contentUrl\":\"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2023\/07\/logo-clinatec.png\",\"width\":650,\"height\":219,\"caption\":\"Fonds Clinatec\"},\"image\":{\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/person\/becc42595d617bcb9ded259df3f001d2\",\"name\":\"Nad\u00e8ge Canton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/be87104c5854186f3c7f966b85f1ef21433980a81595063afefbfa0df8bb34f3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/be87104c5854186f3c7f966b85f1ef21433980a81595063afefbfa0df8bb34f3?s=96&d=mm&r=g\",\"caption\":\"Nad\u00e8ge Canton\"},\"url\":\"https:\/\/fonds-clinatec.fr\/en\/author\/nadegecanton\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"When infrared light stabilises Parkinson's disease - Fonds Clinatec","description":"Read the article in Le Monde on the work of Professor Chabard\u00e8s presented at the World Congress of Stereotactic and Functional Neurosurgery in Chicago.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/","og_locale":"en_US","og_type":"article","og_title":"When infrared light stabilises Parkinson's disease - Fonds Clinatec","og_description":"Read the article in Le Monde on the work of Professor Chabard\u00e8s presented at the World Congress of Stereotactic and Functional Neurosurgery in Chicago.","og_url":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/","og_site_name":"Fonds Clinatec","article_published_time":"2024-09-09T15:10:16+00:00","article_modified_time":"2024-09-10T08:05:40+00:00","og_image":[{"width":593,"height":592,"url":"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png","type":"image\/png"}],"author":"Nad\u00e8ge Canton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nad\u00e8ge Canton","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#article","isPartOf":{"@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/"},"author":{"name":"Nad\u00e8ge Canton","@id":"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/person\/becc42595d617bcb9ded259df3f001d2"},"headline":"When infrared light stabilises Parkinson&#8217;s disease","datePublished":"2024-09-09T15:10:16+00:00","dateModified":"2024-09-10T08:05:40+00:00","mainEntityOfPage":{"@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/"},"wordCount":514,"publisher":{"@id":"https:\/\/fonds-clinatec.fr\/en\/#organization"},"image":{"@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png","articleSection":["(PBM) Photobiomodulation","News","Press"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/","url":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/","name":"When infrared light stabilises Parkinson's disease - Fonds Clinatec","isPartOf":{"@id":"https:\/\/fonds-clinatec.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#primaryimage"},"image":{"@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png","datePublished":"2024-09-09T15:10:16+00:00","dateModified":"2024-09-10T08:05:40+00:00","description":"Read the article in Le Monde on the work of Professor Chabard\u00e8s presented at the World Congress of Stereotactic and Functional Neurosurgery in Chicago.","breadcrumb":{"@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#primaryimage","url":"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png","contentUrl":"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2028\/11\/NIR.png","width":593,"height":592,"caption":"d\u00e9monstrateur NIR, implant c\u00e9r\u00e9bral pour lutter contre la maladie de Parkinson"},{"@type":"BreadcrumbList","@id":"https:\/\/fonds-clinatec.fr\/en\/when-infrared-light-stabilises-parkinsons-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/fonds-clinatec.fr\/en\/homepage\/"},{"@type":"ListItem","position":2,"name":"When infrared light stabilises Parkinson&#8217;s disease"}]},{"@type":"WebSite","@id":"https:\/\/fonds-clinatec.fr\/en\/#website","url":"https:\/\/fonds-clinatec.fr\/en\/","name":"Fonds Clinatec","description":"Make the impossible possible","publisher":{"@id":"https:\/\/fonds-clinatec.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fonds-clinatec.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fonds-clinatec.fr\/en\/#organization","name":"Fonds Clinatec","url":"https:\/\/fonds-clinatec.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2023\/07\/logo-clinatec.png","contentUrl":"https:\/\/fonds-clinatec.fr\/wp-content\/uploads\/2023\/07\/logo-clinatec.png","width":650,"height":219,"caption":"Fonds Clinatec"},"image":{"@id":"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/person\/becc42595d617bcb9ded259df3f001d2","name":"Nad\u00e8ge Canton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fonds-clinatec.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/be87104c5854186f3c7f966b85f1ef21433980a81595063afefbfa0df8bb34f3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/be87104c5854186f3c7f966b85f1ef21433980a81595063afefbfa0df8bb34f3?s=96&d=mm&r=g","caption":"Nad\u00e8ge Canton"},"url":"https:\/\/fonds-clinatec.fr\/en\/author\/nadegecanton\/"}]}},"_links":{"self":[{"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/posts\/7219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/comments?post=7219"}],"version-history":[{"count":1,"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/posts\/7219\/revisions"}],"predecessor-version":[{"id":7220,"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/posts\/7219\/revisions\/7220"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/media\/6897"}],"wp:attachment":[{"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/media?parent=7219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/categories?post=7219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fonds-clinatec.fr\/en\/wp-json\/wp\/v2\/tags?post=7219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}